| Q47553443 | A Patient-Held Smartcard With a Unique Identifier and an mHealth Platform to Improve the Availability of Prenatal Test Results in Rural Nigeria: Demonstration Study. |
| Q38861043 | A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria |
| Q37897305 | AIDS in Africa |
| Q39984106 | Acceptability of prenatal diagnosis by a sample of parents of sickle cell anemia patients in Cameroon (sub-Saharan Africa). |
| Q35898566 | Adolescents with sickle cell anaemia: Experience in a private tertiary hospital serving a tertiary institution |
| Q40932692 | Advances in the prenatal and molecular diagnosis of the hemoglobinopathies and thalassemias |
| Q37413923 | An observational study of children with sickle cell disease in Kilifi, Kenya |
| Q24197977 | Antibiotics for treating community acquired pneumonia in people with sickle cell disease |
| Q24245077 | Antibiotics for treating community acquired pneumonia in people with sickle cell disease |
| Q39007637 | Antibiotics for treating community-acquired pneumonia in people with sickle cell disease |
| Q45911215 | Attitudes of Ghanaian women toward genetic testing for sickle cell trait |
| Q24240355 | Blood transfusions for treating acute chest syndrome in people with sickle cell disease |
| Q24240450 | Blood transfusions for treating acute chest syndrome in people with sickle cell disease |
| Q38940854 | Blood transfusions for treating acute chest syndrome in people with sickle cell disease. |
| Q60923183 | CHRONIC KIDNEY DISEASE AMONGST SICKLE CELL ANAEMIA PATIENT AT THE UNIVERSITY OF MAIDUGURI TEACHING HOSPITAL, NORTH EASTERN NIGERIA: A STUDY OF PREVALENCE AND RISK FACTORS |
| Q41176950 | Clinico-Haematological Profile of Hereditary Haemolytic Anaemias in a Tertiary Health Care Hospital in South India |
| Q57688874 | Conjugate Haemophilus influenzae type b vaccines for sickle cell disease |
| Q24186131 | Conjugate Haemophilus influenzae type b vaccines for sickle cell disease |
| Q24195046 | Conjugate Haemophilus influenzae type b vaccines for sickle cell disease |
| Q33770373 | Current knowledge in the management of children and adolescents with sickle cell disease: Part 1, Physiological issues |
| Q42276708 | Effect of sickle cell crises on glomerular filtration rate in children with sickle cell disease in Ilorin, Nigeria |
| Q48120021 | Effectiveness of preoperative screening for sickle cell disease in a population with a newborn screening program: a cohort study |
| Q36795088 | Falciparum malaria infection in a case of sickle cell trait; unbalancing the balanced polymorphism |
| Q35757615 | Genetic epidemiology of the beta s gene |
| Q34776013 | High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya |
| Q50632207 | Hypodontia in an adolescent with the HbSC genotype: a case report. |
| Q24242567 | Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease |
| Q38849098 | Lack of mortality in 22 children with sickle cell anemia and severe malarial anemia |
| Q37306760 | Malaria as a cause of morbidity and mortality in children with homozygous sickle cell disease on the coast of Kenya |
| Q24244348 | Malaria chemoprophylaxis in sickle cell disease |
| Q24247938 | Malaria chemoprophylaxis in sickle cell disease |
| Q28140217 | Malaria chemoprophylaxis with tafenoquine: a randomised study |
| Q92639559 | Malaria in patients with sickle cell anaemia: burden, risk factors and outcome at the Laquintinie hospital, Cameroon |
| Q33746605 | Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization |
| Q46430885 | Multiple contributors to iron deficiency and anemia in Senegal |
| Q36870605 | Nonhematopoietic Nrf2 dominantly impedes adult progression of sickle cell anemia in mice. |
| Q43956382 | Observations on a new enzyme immunoassay (JOSHUA Sickle Screen®) for sickle cell screening in a rural hospital |
| Q24186614 | Phytomedicines (medicines derived from plants) for sickle cell disease |
| Q24201601 | Phytomedicines (medicines derived from plants) for sickle cell disease |
| Q24234577 | Phytomedicines (medicines derived from plants) for sickle cell disease |
| Q24246812 | Phytomedicines (medicines derived from plants) for sickle cell disease |
| Q24247853 | Phytomedicines (medicines derived from plants) for sickle cell disease |
| Q49985049 | Phytomedicines (medicines derived from plants) for sickle cell disease. |
| Q35813026 | Prevalence of hemoglobin S trait among blood donors: a cross-sectional study |
| Q25256808 | Rapid screening for glucose-6-phosphate dehydrogenase deficiency and haemoglobin polymorphisms in Africa by a simple high-throughput SSOP-ELISA method |
| Q41854803 | Renal medullary cancer in a patient with sickle cell trait |
| Q34401239 | Risk factors for high cerebral blood flow velocity and death in Kenyan children with Sickle Cell Anaemia: role of haemoglobin oxygen saturation and febrile illness |
| Q33835732 | Safety and benefits of interventions to increase folate status in malaria-endemic areas |
| Q60045306 | Safety and effectiveness of antimalarial therapy in sickle cell disease: a systematic review and network meta-analysis |
| Q57321346 | Sickle Cell Disease in Africa and the Arabian Peninsula: Current Management and Challenges |
| Q36263159 | Sickle cell disease and malaria |
| Q37001823 | Sickle cell disease in Africa: a neglected cause of early childhood mortality |
| Q36715984 | Sickle cell disease in Africa: burden and research priorities |
| Q80788431 | Sickle cell disease in central India |
| Q35221368 | Sickle cell disease in the Sudan. Clinical and biochemical aspects. Minireview based on a doctoral thesis |
| Q53127392 | Sickle cell disease: New opportunities and challenges in Africa |
| Q35560041 | Sickle cell disease: health promotion and maintenance and the role of primary care nurse practitioners |
| Q38074184 | Systematic review of current and emerging strategies for reducing morbidity from malaria in sickle cell disease |
| Q58732496 | The clinical presentation, utilization, and outcome of individuals with sickle cell anaemia presenting to urban emergency department of a tertiary hospital in Tanzania |
| Q33932507 | The emerging understanding of sickle cell disease |
| Q60045908 | The global burden of sickle cell disease in children under five years of age: a systematic review and meta-analysis |
| Q40699259 | The pathophysiology of the sickle hemoglobinopathies and implications for perioperative management |
| Q35279487 | Types of anaemic crises in paediatric patients with sickle cell anaemia seen in Enugu, Nigeria |